# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stephens & Co. analyst Scott Fidel reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $410 price target.
Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $393 to $405.
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively imp...
Cigna reported Q2 sales of $60.52 billion, up 25% YoY, beating estimates. Growth was driven by Evernorth Health Services' c...
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...